ORIGINAL PAPER
Ischaemic stroke in women and men – in-hospital prognosis
1
Clinic of Neurology, Swietokrzyskie Neurology Centre, Kielce, Poland
2
1st Clinic of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Centre, Kielce, Poland
3
Collegium Medicum, University of Jan Kochanowski, Kielce, Poland
4
3rd Department of Internal Diseases and Cardiology, Warsaw Medical University, Warsaw, Poland
5
Department of Internal Diseases and Diabetology, Hospital St. Alexander, Kielce, Poland
Submission date: 2022-02-18
Acceptance date: 2022-03-17
Publication date: 2022-03-31
Medical Studies 2022;38(1):22-30
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Stroke is one of the most common causes of death and the leading cause of disability in the adult population worldwide. The risk of stroke increases with age in both men and women, but women have a higher rate of mortality and disability following stroke.
Aim of the research:
To compare the in-hospital mortality in men and women with ischaemic stroke and to identify factors that predispose to death.
Material and methods:
This retrospective, single-centre study included patients with acute ischaemic stroke hospitalized in the reference neurological centre in 2013–2014. The study population consisted of 2000 patients, of whom 50.5% were men. Data on age, sex, comorbidities, results of additional tests, and the course of hospitalization were analysed.
Results:
In-hospital mortality was 15.9% and was higher in women than men (17.9% vs. 14%, p = 0.02). Women were older than men (77.3 vs. 69.5 years, p < 0.001). In women, age ≥ 75 years (OR = 2.507), chronic obstructive pulmonary disease (COPD) (OR = 2.231), and haemorrhagic transformation of the stroke site (OR = 4.77) increased the risk of in-hospital mortality. In men, a history of myocardial infarction (OR = 2.295) and a glomerular filtration rate (GFR) < 60 ml/min/1.73 m2 (OR = 1.774) increased the risk of in-hospital death.
Conclusions:
Better knowledge of the predictors that increase the risk of an adverse stroke may open more avenues for preventive intervention and reduce serious post-stroke complications. Further observations on potential gender differences in risk factors for adverse prognosis in acute stroke are needed to reduce in-hospital deaths.
Stroke is one of the most common causes of death and the leading cause of disability in the adult population worldwide. The risk of stroke increases with age in both men and women, but women have a higher rate of mortality and disability following stroke.
Aim of the research:
To compare the in-hospital mortality in men and women with ischaemic stroke and to identify factors that predispose to death.
Material and methods:
This retrospective, single-centre study included patients with acute ischaemic stroke hospitalized in the reference neurological centre in 2013–2014. The study population consisted of 2000 patients, of whom 50.5% were men. Data on age, sex, comorbidities, results of additional tests, and the course of hospitalization were analysed.
Results:
In-hospital mortality was 15.9% and was higher in women than men (17.9% vs. 14%, p = 0.02). Women were older than men (77.3 vs. 69.5 years, p < 0.001). In women, age ≥ 75 years (OR = 2.507), chronic obstructive pulmonary disease (COPD) (OR = 2.231), and haemorrhagic transformation of the stroke site (OR = 4.77) increased the risk of in-hospital mortality. In men, a history of myocardial infarction (OR = 2.295) and a glomerular filtration rate (GFR) < 60 ml/min/1.73 m2 (OR = 1.774) increased the risk of in-hospital death.
Conclusions:
Better knowledge of the predictors that increase the risk of an adverse stroke may open more avenues for preventive intervention and reduce serious post-stroke complications. Further observations on potential gender differences in risk factors for adverse prognosis in acute stroke are needed to reduce in-hospital deaths.
REFERENCES (31)
1.
Girijala RL, Sohrabji F, Bush RL. Sex differences in stroke: review of current knowledge and evidence. Vasc Med 2017; 22: 135-145.
2.
Stróżyńska E, Ryglewicz D. Czynniki ryzyka udaru mózgu u kobiet. Pol Prz Neurol 2013; 9: 135-140.
3.
Czarnecka D, Zabojszcz M. Nadciśnienie tętnicze a udar mózgu. Choroby Serca i Naczyń 2004; 1: 19-25.
4.
GBD 2016 Lifetime Risk of Stroke Collaborators. Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, Abyu GY, Ademi Z, Agarwal G, Ahmed MB, Akinyemi RO, Al-Raddadi R, Aminde LN, Amlie-Lefond C, Ansari H, Asayesh H, Asgedom SW, Atey TM, Ayele HT, Banach M, Banerjee A, Barac A, Barker-Collo SL, Bärnighausen T, Barregard L, Basu S, Bedi N, Behzadifar M, Béjot Y, Bennett DA, Bensenor IM, Berhe DF, Boneya DJ, Brainin M, Campos-Nona- to IR, Caso V, Castañeda-Orjuela CA, Rivas JC, Catalá-López F, Christensen H, Criqui MH, Damasceno A, Dandona L, Dandona R, Davletov K, de Courten B, deVeber G, Dokova K, Edessa D, Endres M, Faraon EJA, Farvid MS, Fischer F, Foreman K, Forouzanfar MH, Gall SL, Gebrehiwot TT, Geleijnse JM, Gillum RF, Giroud M, Goulart AC, Gupta R, Gupta R, Hachinski V, Hamadeh RR, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Hegazy MI, Hibstu DT, James SL, Jeemon P, John D, Jonas JB, Jóźwiak J, Kalani R, Kandel A, Kasaeian A, Kengne AP, Khader YS, Khan AR, Khang YH, Khubchandani J, Kim D, Kim YJ, Kivima- ki M, Kokubo Y, Kolte D, Kopec JA, Kosen S, Kravchen- ko M, Krishnamurthi R, Kumar GA, Lafranconi A, Lavados PM, Legesse Y, Li Y, Liang X, Lo WD, Lorkowski S, Lotufo PA, Loy CT, Mackay MT, Abd El Razek HM, Mahdavi M, Majeed A, Malekzadeh R, Malta DC, Mamun AA, Mantovani LG, Martins SCO, Mate KK, Mazidi M, Meha- ta S, Meier T, Melaku YA, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Miazgowski T, Miller TR, Ibra- him NM, Mohammed S, Mokdad AH, Moosazadeh M, Moran AE, Musa KI, Negoi RI, Nguyen M, Nguyen QL, Nguyen TH, Tran TT, Nguyen TT, Anggraini Nin- grum DN, Norrving B, Noubiap JJ, O’Donnell MJ, Olagunju AT, Onuma OK, Owolabi MO, Parsaeian M, Patton GC, Piradov M, Pletcher MA, Pourmalek F, Pra- kash V, Qorbani M, Rahman M, Rahman MA, Rai RK, Ranta A, Rawaf D, Rawaf S, Renzaho AM, Robinson SR, Sahathevan R, Sahebkar A, Salomon JA, Santalucia P, Santos IS, Sartorius B, Schutte AE, Sepanlou SG, Shafieesa- bet A, Shaikh MA, Shamsizadeh M, Sheth KN, Sisay M, Shin MJ, Shiue I, Silva DAS, Sobngwi E, Soljak M, Sorensen RJD, Sposato LA, Stranges S, Suliankatchi RA, Tabarés-Seisdedos R, Tanne D, Nguyen CT, Thakur JS, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Nguyen LT, Truelsen T, Tsilimparis N, Tyrovolas S, Ukwaja KN, Uthman OA, Varakin Y, Vasankari T, Venketasubramanian N, Vlassov VV, Wang W, Werdecker A, Wolfe CDA, Xu G, Yano Y, Yonemoto N, Yu C, Zaidi Z, El Sayed Zaki M, Zhou M, Ziaeian B, Zipkin B, Vos T, Naghavi M, Mur- ray CJL, Roth GA. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med 2018; 379: 2429-2437.
5.
Persky RW, Turtzo LC, McCullough LD. Stroke in women: disparities and outcomes. Curr Cardiol Rep 2010; 12: 6-13.
6.
Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 2009; 40: 1032-1037.
7.
Reeves MJ, Bushnell CD, Howard G, Gargano JW, Dun- can PW, Lynch G, Khatiwoda A, Lisabeth L. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008; 7: 915-926.
8.
Ong CT, Wong YS, Sung SF, Wu CS, Hsu YC, Su YH, Hung LC. Sex-related differences in the risk factors for in-hospital mortality and outcomes of ischemic stroke patients in rural areas of Taiwan. PLoS One 2017; 12: e0185361.
9.
Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigo- bin C, Cheung AM. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005; 36: 809-814.
10.
Santalucia P, Pezzella FR, Sessa M, Monaco S, Torgano G, Anticoli S, Zanoli E, Maimone Baronello M, Paciaroni M, Caso V. Sex differences in clinical presentation, severity and outcome of stroke: results from a hospital-based registry. Eur J Intern Med 2013; 24: 167-171.
11.
Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Carsten Leffmann C, RWC Janzen, Rother J, Buecker-Nott HJ, Berger K. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004; 164: 1761-1768.
12.
Andersen KK, Andersen ZJ, Olsen TS. Predictors of early and late case-fatality in a nationwide Danish study of 26,818 patients with first-ever ischemic stroke. Stroke 2011; 42: 2806-2812.
13.
Kortazar-Zubizarreta I, Pinedo-Brochado A, Azkune-Cal- le I, Aguirre-Larracoechea U, Gomez-Beldarrain M, Garcia- Monco JC. Predictors of in-hospital mortality after ischemic stroke: a prospective, single-center study. Health Sci Rep 2019; 2: e110.
14.
Ong CT, Wong YS, Wu CS, Su YH. Atrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patients. Ther Clin Risk Manag 2016; 12: 1057-1064.
15.
Syta-Krzyżanowska A, Chorąży M, Karpowicz B, Drozdowski W. Ocena wpływu czynników ryzyka chorób sercowo-naczyniowych na śmiertelność w udarze mózgu. Aktual Neurol 2013; 13: 62-67.
16.
Dahl S, Hjalmarsson C, Andersson B. Sex differences in risk factors, treatment, and prognosis in acute stroke. Womens Health (Lond) 2020; 16: 1745506520952039.
17.
Akhtar N, Kate M, Kamran S, Singh R, Bhutta Z, Saqqur M, Elzouki AN, Babu B, Bourke P, Morgan D, Joseph S, Jose N, Francis R, Imam Y, Amir N, Own A, Shuaib A. Sex-specific differences in short-term and long-term outcomes in acute stroke patients from Qatar. Eur Neurol 2020; 83: 154-161.
18.
Passowicz-Muszyńska E, Gostkowska-Malec A, Jankowska R, Piesiak P. Przewlekła obturacyjna choroba płuc a choroby układu sercowo-naczyniowego. Pneumonol Alergol Pol 2010; 78: 28-32.
19.
Soler EP, Ruiz VC. Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev 2010; 6: 138-149.
20.
Chou CC, Lien LM, Chen WH, Wu MS, Lin SM, Chiu HC, Chiou HY, Bai CH. Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: a population-based study. Stroke 2011; 42: 2120-2125.
21.
Kapłon-Cieślicka A, Budnik M, Gawałko M, Peller M, Gorczyca I, Michalska A, Babiarz A, Bodys A, Uliński R, Żochowski M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart 2019; 105: 1310-1315.
22.
Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010; 341: c4249.
23.
Olszanecka A, Czarnecka D. Nadciśnienie tętnicze u kobiet. Kardiologia po Dyplomie 2013; 12: 14-22.
24.
Howard VJ, Lackland DT, McVay J, Meschia JF, Mun- tner P, Oparil S, Rightmyer M, Taylor HA. Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension. Stroke 2015; 46: 1595-1600.
25.
Rydberg DM, Mejyr S, Loikas D, Schenck-Gustafsson K, von Euler M, Malmström RE. Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs. Eur J Clin Pharmacol 2018; 74: 1165-1173.
26.
Szczepaniak-Chicheł L, Tykarski A. Gender-related differences in the management of arterial hypertension in women. Arterial Hyperten 2009; 13: 349-361.
27.
Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005; 165: 1410-1419.
28.
Wańkowicz P, Nowacki P, Gołąb-Janowska M. Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range. Arch Med Sci 2019; 15: 1217-1222.
29.
Friedman PJ. Atrial fibrillation after stroke in the elderly. Stroke 1991; 22: 209-214.
30.
Marzona I, Proietti M, Farcomeni A, Romiti GF, Romanazzi I, Raparelli V, Basili S, Lip GYH, Nobili A, Roncaglioni MC. Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients. Int J Cardiol 2018; 269: 182-191.
31.
Senoo K, Lip GY. Female sex, time in therapeutic range, and clinical outcomes in atrial fibrillation patients taking warfarin. Stroke 2016; 47: 1665-1668.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
